This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Wolfgang Schade - Innovation in Active Peptides
Introduction
Wolfgang Schade is a notable inventor based in Jena, Germany, renowned for his contribution to the field of active peptides. With a single patent to his name, he exemplifies the spirit of innovation in the scientific community.
Latest Patents
The patent for which Wolfgang Schade is recognized pertains to "Chrysospermins," active peptides derived from Apiocrea chrysosperma. This invention is pivotal in exploring the therapeutic applications of these unique compounds, showcasing the potential benefits of natural peptides in the medical field.
Career Highlights
Wolfgang Schade's career is highlighted by his association with Hoechst Aktiengesellschaft, a prominent company in the pharmaceuticals and biotechnology sector. His work focuses on advancing the understanding and application of active peptides, paving the way for future innovations in health and medicine.
Collaborations
Throughout his career, Wolfgang Schade has collaborated with notable colleagues, including Jörg Metzger and Brigitte Schlegel. Together, they have contributed to the research and development of innovative solutions that enhance the efficacy of biomedical applications.
Conclusion
In summary, Wolfgang Schade stands out as an inventor making strides in the field of active peptides. His patent on Chrysospermins highlights the potential of natural compounds in medicine, reinforcing the importance of research and collaboration in driving innovation forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile